For a small percentage of chronic lung disease patients, the environment -- not smoking or genetics -- plays the primary role in their development of the disease.
A new study reveals that methylprednisolone and budesonide inhalation suspension showed limited differences in young patients with bronchial asthma attacks.
According to new data, the use of ibuprofen or acetaminophen did not affect the length of a hospital stay for children with asthma.
Regeneron Pharmaceuticals and Sanofi revealed positive results from a study of dupilumab in adult patients with asthma.
The school-based program “Building Bridges for Asthma Care” significantly decreased school absenteeism among children with asthma in inner-city schools enrolled in the program.
A study to be presented at the American Thoracic Society (ATS) 2015 International Conference shows that a number of children with asthma may have a sensitivity to peanuts but do no know it.
A case study examined the effectiveness of the smartphone app Asthma Ally, which connects a person with their allergist's office and enables symptom recording.
Spirometry was underutilized for asthma diagnosis and management in US adults, according to researchers.
One-in-three Americans lives in the “sneeziest and wheeziest” cities and regions where they are exposed to both ragweed pollen and ozone smog pollution that can worsen respiratory allergies and asthma.
A new study of around 2,000 patients with acute asthma revealed women are 60% more likely to be hospitalized when being treated for the condition in the emergency department.
A Cincinnati Children's Hospital Medical Center study shows that pharmacies may be able to collaborate with families and physicians to reduce asthma-related illness.
MyAirCoach, a pan-European project lead by the EFA, is recruiting patients to develop a monitoring device which is integrated with mobile technology to help people with asthma reduce their risk of an asthma attack.
On May 5th, World Asthma Day 2015, the National Institutes of Health (NIH) issued a statement reaffirming its commitment to advance the understanding of asthma and develop effective strategies to manage and prevent the disease.
The resource will provide quality assured, standardized asthma training, specifically designed for anyone working with children or young people.
Effective pulmonary function tests on their own, combining the diagnostic power of spirometry and plethysmography gives clinicians a frontline weapon in the management of chronic lung diseases like asthma and COPD.
GlaxoSmithKline (GSK) and Theravance, Inc, have announced that Breo Ellipta has been approved by the Food and Drug Administration (FDA) for the once-daily treatment of asthma in patients ages 18 years and older.
The AARC has asked respiratory therapists in Texas to support an initiative that would establish a strategic plan for asthma and COPD.
Researchers explored the previously unproven role of the calcium sensing receptor (CaSR) in causing asthma, a disease which affects 300 million people worldwide.
According to a review published in Allergy, the prevalence of nonsteroidal anti-inflammatory drug-exacerbated respiratory disease is approximately 9% among individuals with asthma.
Cincinnati Children's Hospital researchers have identified a biological basis for asthmatic children who do not respond well to corticosteroid treatment.